Navigation Links
Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest

SEATTLE, March 17 /PRNewswire-FirstCall/ -- Craig Philips, President of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) will present at the 8th Annual WBBA Invest Northwest Conference on Wednesday, March 18th at 10:10 AM in the Harbor Dining Room of the Bell Harbor Conference Center.

Philips was named President of CTI in August of 2008. Prior to CTI, Philips was Vice President and General Manager of Bayer Healthcare Oncology, with direct responsibilities for all Development and Commercial Operations. Starting in 2006 Philips led Bayer's U.S. oncology operations, following the integration of the U.S. oncology businesses from Berlex and Bayer. He oversaw the U.S. oncology operations, with sales of $350 million and a staff of over 150. Prior to Bayer, Philips was the head of Berlex Oncology as Vice President and General Manager at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering Plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, cardiology, and CNS.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at

                       WBBA Invest Northwest Conference
                 CTI Presentation: Wednesday, March 18, 2009
                     10:10 AM PST/1:10 PM EST/6:10 PM CET
              Harbor Dining Room, Bell Harbor Conference Center
            Audio webcast with slides at

     Media Contact:
     Dan Eramian
     T: 206.272.4343
     C: 206.854.1200

     Investors Contact:
     Ed Bell
     T: 206.282.7100
     Lindsey Jesch Logan
     T: 206.272.4347
     F: 206.272.4434

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
2. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
3. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
4. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
5. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
6. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
7. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
8. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
9. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
10. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
11. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also ... buy during the Black Friday and Cyber Monday massage chair sales to ... Internet high and low to find the best massage chair deals, they can see ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology: